- Joined
- Oct 11, 2015
- Messages
- 6
- Reaction score
- 0
- Points
- 0
The plenary was interesting with good preliminary data. Here is the abstract.ASTRO 2015 Plenary has a RCT of elective nodal irradiation in thoracic esophageal cancer.
IMHO stents before XRT are frowned upon (there are reports of mortality), but once it's in, you can't deny this patient a curative intent treatment.
From treatment response or tumor?How would you managed a TEF?
Sorry full thought - how would you manage a TEF from tumor without stenting?From treatment response or tumor?
Sorry full thought - how would you manage a TEF from tumor without stenting?
IMHO stents before XRT are frowned upon (there are reports of mortality), but once it's in, you can't deny this patient a curative intent treatment.
I don't see why not? Let them take it out and see if patient can swallow.
Case reports that I've seen deal with esophageal perforation and also aspiration
And what if they can't? If the patient was so stenosed that dilatation alone wasn't enough and the patient needed a stent placed, wouldn't you want to treat the cancer around it first, then and only then remove the stent?
We've treated with esophageal stents in place even for non-TEF cases. We're generally treating them palliatively, FWIW. Why not leave the stent in place, and talk to the physicists about incorporating that back scatter dose into the plan to avoid excessive hotspots?
I think you could, But it's taking a risk and if something happens You'll look at it and say I should have had it taken out. Everyone's gonna be blaming RT for a perf